Belvedere Trading LLC Inmune Bio, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022
SELL
$9.97 - $20.38 $161,284 - $329,687
-16,177 Closed
0 $0
Q3 2021

Oct 19, 2021
SELL
$14.13 - $27.85 $166,606 - $328,379
-11,791 Reduced 42.16%
16,177 $302,000
Q2 2021

Jul 23, 2021
BUY
$9.29 - $19.33 $259,822 - $540,621
27,968 New
27,968 $588,000

Others Institutions Holding INMB

# of Institutions
71
Shares Held
5.92M
Call Options Held
243K
Put Options Held
46.4K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $82M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email